Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depression.
Sign Up to like & getrecommendations! Published in 2023 at "Bipolar disorders"
DOI: 10.1111/bdi.13319
Abstract: OBJECTIVES The aim of this study was to repurpose a drug for the treatment of bipolar depression. METHODS A gene expression signature representing the overall transcriptomic effects of a cocktail of drugs widely prescribed to… read more here.
Keywords: treat bipolar; bipolar depression; trimetazidine; depression ... See more keywords